CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,101 enrolled
Drug / intervention
LSM assessed by Elastographic Techniquesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03426358
NCT03426358N/ACompleted
CompareCT.gov

Usefulness of Liver Stiffness Measurement in Predicting Hepatic Veno-Occlusive Disease Development in Patients Who Undergo HSCT: a Multicentric Prospective Study

IRCCS Azienda Ospedaliero-Universitaria di Bologna·interventional·Posted Feb 8, 2018·Updated Apr 14, 2022

In Brief

A clinical study evaluating LSM assessed by Elastographic Techniques for Veno Occlusive Disease, Hepatic and 2 related conditions. Completed, enrolled 1,101 participants across 37 sites.

Detailed Summary

ELASTOVOD is a prospective multicenter study, involving several centers of Onco-haematology in Italy. Investigators perform hepatic elastographic measurements (with Transient Elastography, ARFI or 2D-SWE) on patients undergoing HSCT, at baseline before transplantation (T0) and at T1/T2/T3 after HSCT (+9/10, +15/17, +22/24). SOS/VOD diagnosis was performed according to clinical criteria.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVeno Occlusive Disease, Hepatic, Sinusoidal Obstruction Syndrome, Stem Cell Transplant Complications
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 8, 2018
Enrollment StartApr 28, 2015
Primary CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 8.4 years ago

Interventions

LSM assessed by Elastographic Techniquesdevice

Performing Transient Elastography, ARFI or 2D-SWE on patients at baseline (within 1 month before HSCT) and after HSCT on days +9/10, +15/17, +22/24